Cardiovascular complications of sleep apnea: role of oxidative stress.
Mohammad BadranNajib AyasIsmail LaherPublished in: Oxidative medicine and cellular longevity (2014)
Obstructive sleep apnea (OSA) occurs in 2% of middle-aged women and 4% of middle-aged men with a higher prevalence among obese subjects. This condition is considered as an independent risk factor for cerebrovascular and cardiovascular diseases. One of the major pathophysiological characteristics of OSA is intermittent hypoxia. Hypoxia can lead to oxidative stress and overproduction of reactive oxygen species, which can lead to endothelial dysfunction, a hallmark of atherosclerosis. Many animal models, such as the rodent model of intermittent hypoxia, mimic obstructive sleep apnea in human patients and allow more in-depth investigation of biological and cellular mechanisms of this condition. This review discusses the role of oxidative stress in cardiovascular disease resulting from OSA in humans and animal models.
Keyphrases
- obstructive sleep apnea
- middle aged
- sleep apnea
- positive airway pressure
- oxidative stress
- cardiovascular disease
- endothelial cells
- reactive oxygen species
- end stage renal disease
- dna damage
- ischemia reperfusion injury
- diabetic rats
- induced apoptosis
- ejection fraction
- risk factors
- high intensity
- newly diagnosed
- type diabetes
- peritoneal dialysis
- cardiovascular events
- chronic kidney disease
- adipose tissue
- prognostic factors
- weight loss
- metabolic syndrome
- pregnant women
- coronary artery disease
- signaling pathway
- bariatric surgery
- endoplasmic reticulum stress
- induced pluripotent stem cells
- heat shock protein